Rare biomarkers in disease management has driven investments toward clinical applications.
This report contains market size and forecasts of Rare Biomarkers Specimen Collection And Stabilization in Global, including the following market information:
- Global Rare Biomarkers Specimen Collection And Stabilization Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Rare Biomarkers Specimen Collection And Stabilization market was valued at 29830 million in 2021 and is projected to reach US$ 50160 million by 2028, at a CAGR of 7.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Circulating Cell Free DNA (ccfDNA) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Rare Biomarkers Specimen Collection And Stabilization include Miltenyi Biotec, QIAGEN, Creatv MicroTech, Veridex, Creative-Bioarray, Genetix, STRECK, INC., Roche and Amgen. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Rare Biomarkers Specimen Collection And Stabilization companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Rare Biomarkers Specimen Collection And Stabilization Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Rare Biomarkers Specimen Collection And Stabilization Market Segment Percentages, by Type, 2021 (%)
- Circulating Cell Free DNA (ccfDNA)
- Circulating Tumor Cells (CTCs)
- Exosomes/Extracellular Vesicles
- Circulating Cell Free RNA (ccfRNA) / miRNA
Global Rare Biomarkers Specimen Collection And Stabilization Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Rare Biomarkers Specimen Collection And Stabilization Market Segment Percentages, by Application, 2021 (%)
Global Rare Biomarkers Specimen Collection And Stabilization Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Rare Biomarkers Specimen Collection And Stabilization Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Rare Biomarkers Specimen Collection And Stabilization revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Rare Biomarkers Specimen Collection And Stabilization revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Miltenyi Biotec
- QIAGEN
- Creatv MicroTech
- Veridex
- Creative-Bioarray
- Genetix
- STRECK, INC.
- Roche
- Amgen
